These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18490459)

  • 1. Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function.
    Spinner JL; Cundiff JA; Kobayashi SD
    Infect Immun; 2008 Aug; 76(8):3754-60. PubMed ID: 18490459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yersinia pestis survival and replication within human neutrophil phagosomes and uptake of infected neutrophils by macrophages.
    Spinner JL; Winfree S; Starr T; Shannon JG; Nair V; Steele-Mortimer O; Hinnebusch BJ
    J Leukoc Biol; 2014 Mar; 95(3):389-98. PubMed ID: 24227798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of
    Dudte SC; Hinnebusch BJ; Shannon JG
    Front Cell Infect Microbiol; 2017; 7():358. PubMed ID: 28848716
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of Neutrophil Primary Granule Release during Yersinia pestis Pulmonary Infection.
    Eichelberger KR; Jones GS; Goldman WE
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils are resistant to Yersinia YopJ/P-induced apoptosis and are protected from ROS-mediated cell death by the type III secretion system.
    Spinner JL; Seo KS; O'Loughlin JL; Cundiff JA; Minnich SA; Bohach GA; Kobayashi SD
    PLoS One; 2010 Feb; 5(2):e9279. PubMed ID: 20174624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia pestis two-component gene regulatory systems promote survival in human neutrophils.
    O'Loughlin JL; Spinner JL; Minnich SA; Kobayashi SD
    Infect Immun; 2010 Feb; 78(2):773-82. PubMed ID: 19933831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Yersinia pestis toxin complex family proteins in resistance to phagocytosis by polymorphonuclear leukocytes.
    Spinner JL; Carmody AB; Jarrett CO; Hinnebusch BJ
    Infect Immun; 2013 Nov; 81(11):4041-52. PubMed ID: 23959716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Yersinia YopJ protein in suppressing interleukin-8 secretion by human polymorphonuclear leukocytes.
    Spinner JL; Hasenkrug AM; Shannon JG; Kobayashi SD; Hinnebusch BJ
    Microbes Infect; 2016 Jan; 18(1):21-9. PubMed ID: 26361732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
    Vagima Y; Zauberman A; Levy Y; Gur D; Tidhar A; Aftalion M; Shafferman A; Mamroud E
    PLoS Pathog; 2015 May; 11(5):e1004893. PubMed ID: 25974210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach.
    Pulsifer AR; Vashishta A; Reeves SA; Wolfe JK; Palace SG; Proulx MK; Goguen J; Bodduluri SR; Haribabu B; Uriarte SM; Lawrenz MB
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871100
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody Opsonization Enhances Early Interactions between Yersinia pestis and Neutrophils in the Skin and Draining Lymph Node in a Mouse Model of Bubonic Plague.
    Shannon JG; Hinnebusch BJ
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.
    Cowan C; Philipovskiy AV; Wulff-Strobel CR; Ye Z; Straley SC
    Infect Immun; 2005 Sep; 73(9):6127-37. PubMed ID: 16113334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of New Virulence Factors and Vaccine Candidates for
    Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
    Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology of Yersinia pestis Infection.
    Bi Y
    Adv Exp Med Biol; 2016; 918():273-292. PubMed ID: 27722867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen.
    Huang XZ; Lindler LE
    Infect Immun; 2004 Dec; 72(12):7212-9. PubMed ID: 15557646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis.
    Du Y; Rosqvist R; Forsberg A
    Infect Immun; 2002 Mar; 70(3):1453-60. PubMed ID: 11854232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Neutrophil Isolation and Degranulation Responses to Yersinia pestis Infection.
    Eichelberger KR; Goldman WE
    Methods Mol Biol; 2019; 2010():197-209. PubMed ID: 31177440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis.
    Pujol C; Bliska JB
    Infect Immun; 2003 Oct; 71(10):5892-9. PubMed ID: 14500510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.
    Weeks S; Hill J; Friedlander A; Welkos S
    Microb Pathog; 2002 May; 32(5):227-37. PubMed ID: 12071679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Connor MG; Pulsifer AR; Chung D; Rouchka EC; Ceresa BK; Lawrenz MB
    mBio; 2018 Feb; 9(1):. PubMed ID: 29463656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.